D. Khuntia

发表

The Impact of Hybrid PET-CT Scan on Overall Oncologic Management, with a Focus on Radiotherapy Planning: A Prospective, Blinded Study

M. Mehta, W. Tomé, S. Perlman, 2009, Technology in cancer research & treatment.

Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer.

Pranshu Mohindra, Deepak Khuntia, Søren M Bentzen, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Helical Tomotherapy as a Means of Delivering Scalp-sparing Whole Brain Radiation Therapy

M. Mehta, T. Mackie, W. Tomé, 2005, Technology in cancer research & treatment.

Phase I trial of simultaneous in-field boost with helical tomotherapy for patients with one to three brain metastases.

B. Yaremko, M. Lock, G. Bauman, 2011, International journal of radiation oncology, biology, physics.

Whole-brain radiotherapy in the management of brain metastasis.

P. Brown, M. Mehta, D. Khuntia, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.

M. Mehta, W. Tomé, M. Ritter, 2007, International journal of radiation oncology, biology, physics.

Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: The University of Wisconsin experience

P. Harari, S. Bentzen, J. Cleary, 2009, Head & neck.

Factors Associated with Improved Survival in Patients with Brain Metastases from Esophageal Cancer: A Retrospective Review

G. Barnett, T. Rice, M. Chidel, 2003, Technology in cancer research & treatment.

Principles and Application of PET in Brain Tumors.

T. Kruser, D. Khuntia, D. Cannon, 2011, PET clinics.

Motexafin gadolinium: a novel radiosensitizer for brain tumors

M. Mehta, D. Khuntia, Gregory M. Richards, 2009, Expert opinion on pharmacotherapy.

Motexa fi n gadolinium injection for the treatment of brain metastases in patients with non-small cell lung cancer

D. Khuntia, Sayana R Thomas, 2007 .

Motexafin gadolinium injection for the treatment of brain metastases in patients with non-small cell lung cancer

D. Khuntia, Sayana R Thomas, 2007, International journal of nanomedicine.

Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer.

Rakesh R. Patel, D. Petereit, W. Tomé, 2012, International journal of radiation oncology, biology, physics.

Dose escalation model for limited-stage small-cell lung cancer.

W. Tomé, D. Khuntia, Noah B Arvidson, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion.

R. Jeraj, P. Harari, T. McCulloch, 2015, International journal of radiation oncology, biology, physics.

Applications in Head and Neck Cancer

P. Harari, D. Khuntia, A. Traynor, 2006 .

Brain metastases: what's new with an old problem?

M. Mehta, M. Tsao, D. Khuntia, 2012, Current opinion in supportive and palliative care.

RapidPlan hippocampal sparing whole brain model version 2-how far can we reduce the dose?

Matthew C. Schmidt, P. Kupelian, F. Reynoso, 2022, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Hippocampal-Sparing Whole Brain Radiotherapy: A “How-To” Technique, Utilizing Helical Tomotherapy and LINAC-based Intensity Modulated Radiotherapy

R. Tolakanahalli, H. Rowley, W. Tomé, 2011 .

A Comprehensive Assessment by Tumor Site of Patient Setup using Daily MVCT Imaging from Over Three Thousand Eight Hundred Helical Tomotherapy Treatments

T. Mackie, W. Tomé, P. Harari, 2009 .

Role for Postoperative Radiation Therapy in Adenoid Cystic Carcinoma of the Head and Neck

R. Esclamado, J. Saxton, T. Carlson, 2004, The Laryngoscope.

Stereotactic Irradiation: Linear Accelerator and Gamma Knife

M. Mehta, W. Tomé, J. Suh, 2012 .

Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3)

P. Brown, C. Hadjipanayis, C. Jan, 2020 .

Strategies to mitigate the effects of whole-brain radiation therapy on neurocognitive function in patients with brain metastases

F. Moraes, D. Shultz, J. Suh, 2017, Applied Radiation Oncology.

Adjuvant Therapy for Patients with Oral Cavity Cancer

P. Harari, R. Manon, D. Khuntia, 2009 .

Preservation of Neurocognitive Function (NCF) with Conformal Avoidance of the Hippocampus during Whole-Brain Radiotherapy (HA-WBRT) for Brain Metastases: Preliminary Results of Phase III Trial NRG Oncology CC001

P. Brown, M. Mehta, W. Tomé, 2018, International Journal of Radiation Oncology*Biology*Physics.

Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery

M. Mehta, W. Tomé, J. Kuo, 2013, Journal of Neuro-Oncology.

Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial.

J. Buckner, P. Brown, C. Hadjipanayis, 2022, JAMA oncology.

FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01): Protocol for the First Prospective Feasibility Study

K. Russell, Ricky A. Sharma, J. Perentesis, 2022, JMIR research protocols.

Phase II Randomized Trial of Postoperative Chemoradiation Plus Cetuximab for High-risk Squamous Cell Carcinoma of the Head and Neck (RTOG 0234)

K. Ang, P. Harari, J. Myers, 2009 .

Image-Guided, Intensity-Modulated Hypofractionated Radiotherapy for Inoperable Non-Small Cell Lung Cancer: Preliminary Results of a Phase I Dose Escalation Study

M. Mehta, W. Tomé, H. Jaradat, 2007 .

Dosimetric Evaluation of Helical IMRT, Traditional IMRT and 3-D Conformal Radiation for Inoperable Non-Small Cell Lung Cancer

M. Mehta, W. Tomé, H. Jaradat, 2007 .

Increased Oral Mucositis after IMRT versus Non-IMRT when Combined with Cetuximab and Cisplatin or Docetaxel for Head and Neck Cancer: Preliminary Results of RTOG 0234

K. Ang, P. Harari, S. Bentzen, 2008 .

In Regard to Brown and Adler.

J. Goldwein, D. Khuntia, Fabienne Hirigoyenberry Lanson, 2015, International journal of radiation oncology, biology, physics.

Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.

M. Mehta, H. Robins, D. Khuntia, 2007, Clinical advances in hematology & oncology : H&O.

Radiosensitizers in Neurooncology

M. Mehta, A. Chakravarti, H. Robins, 2009 .

64 Radiosensitizers Neurooncology

M. Mehta, A. Chakravarti, H. Robins, 2009 .

Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.

P. Brown, M. Mehta, S. Bentzen, 2013, Neuro-oncology.

Current Strategies in Whole-brain Radiation Therapy for Brain Metastases

M. Mehta, D. Khuntia, 2005, Neurosurgery.

A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.

Meihua Wang, M. Mehta, M. Schell, 2013, International journal of radiation oncology, biology, physics.

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.

P. Brown, M. Gilbert, M. Mehta, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial.

K. Russell, J. Bradley, Ricky A. Sharma, 2022, JAMA oncology.

Recurrence‐free survival rates after external‐beam radiotherapy for patients with clinical T1–T3 prostate carcinoma in the prostate‐specific antigen era

C. Reddy, E. Klein, P. Kupelian, 2004, Cancer.

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.

J. Buckner, P. Brown, C. Hadjipanayis, 2017, The Lancet. Oncology.

Optimizing whole brain radiotherapy dose and fractionation: Results from a prospective phase III trial (NCCTG N107C (Alliance)/CEC.3).

J. Buckner, P. Brown, C. Hadjipanayis, 2019, International journal of radiation oncology, biology, physics.

Chapter 28 – Benign Brain Tumors: Meningiomas and Vestibular Schwannomas

M. Chan, B. Anderson, D. Khuntia, 2016 .

Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.

K. Ang, P. Harari, Q. Zhang, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933.

M. Mehta, W. Tomé, J. Kuo, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Current Treatment Strategies for Brain Metastasis and Complications From Therapeutic Techniques: A Review of Current Literature

John H Suh, Deepak Khuntia, M. Mehta, 2010, American journal of clinical oncology.

Dose Escalated, Hypofractionated Radiotherapy Using Helical Tomotherapy for Inoperable Non-Small Cell Lung Cancer: Preliminary Results of a Risk-Stratified Phase I Dose Escalation Study

H Jaradat, S M Bentzen, W. Tomé, 2008, Technology in cancer research & treatment.

Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy.

Dinesh Tewatia, Deepak Khuntia, Howard Rowley, 2010, International journal of radiation oncology, biology, physics.

Simultaneously Integrated Boost to Multiple Brain Metastases during Whole Brain Radiation Therapy-Hippocampal Avoidance

M. Mehta, W. Tomé, J. Kuo, 2010 .

Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study.

M. Mehta, T. Mackie, W. Tomé, 2007, International journal of radiation oncology, biology, physics.

N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease

J. Buckner, P. Brown, C. Hadjipanayis, 2016 .

Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation.

M. Mehta, W. Tomé, J. Kuo, 2007, International journal of radiation oncology, biology, physics.

Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy?

E. Blackstone, M. Vogelbaum, T. Rice, 2006, The Annals of thoracic surgery.

Motexafin gadolinium: a promising radiation sensitizer in brain metastasis

D. Khuntia, Sayana R Thomas, S. Thomas, 2011, Expert opinion on drug discovery.

Current practices of driving restriction implementation for patients with brain tumors

M. Mehta, J. Kuo, D. Khuntia, 2011, Journal of Neuro-Oncology.

Radiation techniques in neuro-oncology

M. Mehta, W. Tomé, D. Khuntia, 2009, Neurotherapeutics.

Contemporary Review of the Management of Brain Metastasis with Radiation

D. Khuntia, 2015 .

Therapeutic advances in malignant glioma: current status and future prospects.

A. Lassman, H. Robins, D. Khuntia, 2009, Neuroimaging clinics of North America.

Motexafin gadolinium: a clinical review of a novel radioenhancer for brain tumors

Deepak Khuntia, M. Mehta, D. Khuntia, 2004, Expert review of anticancer therapy.

Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy.

M. Markman, D. Khuntia, A. Kennedy, 2003, Gynecologic oncology.

Imaging and radiation therapy: Current trends and future possibilities

Aryavarta M S Kumar, A. Godley, D. Khuntia, 2013, Applied Radiation Oncology.

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

L. Potters, J. Ciezki, C. Reddy, 2002, International journal of radiation oncology, biology, physics.

Significant suppression of radiation dermatitis in breast cancer patients using a topically applied adrenergic vasoconstrictor

W. E. Fahl, J. Eickhoff, J. Cleary, 2017, Radiation oncology.

Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes.

Patrick A Kupelian, Arul Mahadevan, Deepak Khuntia, 2005, International journal of radiation oncology, biology, physics.

Motexafin gadolinium: a novel radiosensitizer for brain tumors

M. Mehta, D. Khuntia, Gregory M. Richards, 2007, Expert review of anticancer therapy.

Therapeutic management of metastatic brain tumors.

M. Mehta, D. Khuntia, Gregory M. Richards, 2007, Critical reviews in oncology/hematology.

Reirradiation for Locoregionally Recurrent Lung Cancer: Outcomes in Small Cell and Non–Small Cell Lung Carcinoma

M. Mehta, T. Campbell, H. Geye, 2014, American journal of clinical oncology.

Advances in Radiation Oncology of Lung Cancer

M. Mehta, D. Khuntia, 2011 .

NRG Oncology CC001: A phase III trial of hippocampal avoidance (HA) in addition to whole-brain radiotherapy (WBRT) plus memantine to preserve neurocognitive function (NCF) in patients with brain metastases (BM).

P. Brown, M. Mehta, W. Tomé, 2019, Journal of Clinical Oncology.

Cognition and Cancer: Brain metastases

M. Mehta, C. Meyers, D. Khuntia, 2008 .

NRG Oncology CC001 Neurocognitive Final Analysis: A Phase III Trial of Hippocampal Avoidance (HA) in Addition to Whole-Brain Radiotherapy (WBRT) Plus Memantine to Preserve Neurocognitive Function (NCF) in Patients With Brain Metastases (BM)

P. Brown, M. Mehta, W. Tomé, 2019, Neurosurgery.

Can Rational Combination of Ultra-high Dose Rate FLASH Radiotherapy with Immunotherapy Provide a Novel Approach to Cancer Treatment?

J. Perentesis, D. Khuntia, R. Sharma, 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).

Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation

Anne Traynor, Deepak Khuntia, Wolfgang A Tomé, 2006, Acta oncologica.

The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy.

P. Brown, D. Bruner, S. Pugh, 2018, Neuro-oncology practice.

Bridging Innovation and Outreach to Overcome Global Gaps in Radiation Oncology Through Information and Communication Tools, Trainee Advancement, Engaging Industry, Attention to Ethical Challenges, and Political Advocacy.

T. Pawlicki, N. Mayr, P. Hardenbergh, 2017, Seminars in radiation oncology.

A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatments.

Bhudatt R Paliwal, Deepak Khuntia, Thomas R Mackie, 2009, International journal of radiation oncology, biology, physics.

Optimizing Whole Brain Radiotherapy Dose and Fractionation: Results from a Prospective Phase III Trial (NCCTG N107C (Alliance)/CEC.3)

J. Buckner, P. Brown, E. Galanis, 2019, International Journal of Radiation Oncology*Biology*Physics.

Overview of the American Society for Radiation Oncology-National Institutes of Health-American Association of Physicists in Medicine Workshop 2015: Exploring Opportunities for Radiation Oncology in the Era of Big Data.

Vojtech Huser, Charles Mayo, Todd McNutt, 2016, International journal of radiation oncology, biology, physics.

Phase II Randomized Trial of Surgery Followed by Chemoradiation Plus Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck (RTOG 0234)

K. Ang, P. Harari, J. Myers, 2007 .

Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.

P. Brown, M. Mehta, S. Bentzen, 2013, Neuro-oncology.

Therapeutic advances in malignant glioma: current status and future prospects.

A. Lassman, D. Khuntia, H. Robins, 2009, Neuroimaging clinics of North America.

Chapter 28 – Benign Brain Tumors: Meningiomas and Vestibular Schwannomas

M. Chan, B. Anderson, D. Khuntia, 2016 .

Clinical investigation: prostateRadical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer

L. Potters, J. Ciezki, C. Reddy, 2004 .

Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer.

M. Mehta, R. Tolakanahalli, W. Tomé, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of prophylactic Tamsulosin ± dexamethasone in patients undergoing prostate 125I seed implants for prostate carcinoma. A randomized double-blind study

J. Ciezki, C. Reddy, E. Klein, 2004 .